IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 122 filers reported holding IVERIC BIO INC in Q4 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,430,894 | +56.2% | 223,218 | +37.4% | 0.01% | +75.0% |
| Q4 2022 | $3,477,369 | +43.2% | 162,418 | +15.7% | 0.00% | +33.3% |
| Q3 2022 | $2,429,000 | +66.3% | 140,426 | -7.5% | 0.00% | +50.0% |
| Q2 2022 | $1,461,000 | -57.8% | 151,855 | -26.1% | 0.00% | -33.3% |
| Q1 2022 | $3,460,000 | -4.9% | 205,580 | -5.6% | 0.00% | 0.0% |
| Q4 2021 | $3,640,000 | +3.0% | 217,680 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $3,535,000 | +109.2% | 217,680 | +11.1% | 0.00% | +100.0% |
| Q2 2021 | $1,690,000 | +75.7% | 195,882 | +25.9% | 0.00% | +100.0% |
| Q1 2021 | $962,000 | +16.7% | 155,632 | +30.6% | 0.00% | 0.0% |
| Q4 2020 | $824,000 | +22.6% | 119,177 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $672,000 | +5.0% | 119,177 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $640,000 | – | 125,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |